the right choice depends on the studys tolerance for injection-related handling, the need for exact receptor selectivity, and whether absorption route itself is a study variable
For questions about medically qualifying diagnoses to access these drugs for purposes other than weight loss, discuss with your doctor
In more than 20,000 patient-years exposure to metformin in clinical trials, there were no reports of lactic acidosis
Food and Drug Administration (FDA) include semaglutide (sold as Ozempic and Wegovy), liraglutide (Saxenda and Victoza), and tirzepatide (Zepbound), a dual GIP/GLP-1 receptor agonist
Carbohydrates are still important to your diet when youre taking semaglutide
News-Medical+3EurekAlert!+3ASMBS+3 To put numbers on it: Surgical patients lost ~58 lbs in two years ( 24% of total body weight, or TBW) GLP-1 patients lost only ~12 lbs ( 4.7% TBW) over the same period EurekAlert!+2News-Medical+2 Even among GLP-1 users who continued therapy for a full year, weight loss averaged only ~7% TBWstill far less than surgical outcomes EurekAlert!+2ASMBS+2 Another rigorous analysis published in JAMA Surgery compared weight loss surgery and GLP-1 receptor agonists over two years